Mana, Melina
Eli Lilly (United States)
3 papers on CoChat
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis
Sanguineti, F., Garot, P., Mana, M., O'h-Ici, D., Hovasse, T., Unterseeh, T., Louvard, Y., Troussier, X., Morice, M.-C., & Garot, J. (2015) · Journal of Cardiovascular Magnetic Resonance
Viral Infections and Immunology ResearchCardiac Imaging and Diagnostics
Cited by 99
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free